Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Risk-based prostate cancer screening: who and how?

Glass AS, Cary KC, Cooperberg MR.

Curr Urol Rep. 2013 Jun;14(3):192-8. doi: 10.1007/s11934-013-0319-8. Review.

2.

Prostate specific antigen testing: age-related interpretation in early prostate cancer detection.

McKenzie PR, Delahunt B, Kench JG, Ross B, Lam Q, deVoss K, Tran HA, Sikaris KA.

Pathology. 2013 Jun;45(4):343-5. doi: 10.1097/PAT.0b013e3283619a77. No abstract available.

PMID:
23619589
3.

Response to the U.S. Preventative Services Task Force decision on prostate cancer screening.

Makovey I, Stephenson AJ, Haywood S.

Curr Urol Rep. 2013 Jun;14(3):168-73. doi: 10.1007/s11934-013-0318-9.

PMID:
23568623
4.

The epidemiology of high-risk prostate cancer.

Punnen S, Cooperberg MR.

Curr Opin Urol. 2013 Jul;23(4):331-6. doi: 10.1097/MOU.0b013e328361d48e. Review.

5.

Overdetection in screening for prostate cancer.

Hugosson J, Carlsson S.

Curr Opin Urol. 2014 May;24(3):256-63. doi: 10.1097/MOU.0000000000000054. Review.

PMID:
24670870
6.

Outcome following active surveillance of men with screen-detected prostate cancer. Results from the Göteborg randomised population-based prostate cancer screening trial.

Godtman RA, Holmberg E, Khatami A, Stranne J, Hugosson J.

Eur Urol. 2013 Jan;63(1):101-7. doi: 10.1016/j.eururo.2012.08.066. Epub 2012 Sep 5.

PMID:
22980443
7.

Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Schröder FH, Hugosson J, Carlsson S, Tammela T, Määttänen L, Auvinen A, Kwiatkowski M, Recker F, Roobol MJ.

Eur Urol. 2012 Nov;62(5):745-52. doi: 10.1016/j.eururo.2012.05.068. Epub 2012 Jun 7.

PMID:
22704366
8.

Should prostate-specific antigen screening be offered to asymptomatic men?

van Vugt HA, Bangma CH, Roobol MJ.

Expert Rev Anticancer Ther. 2010 Jul;10(7):1043-53. doi: 10.1586/era.10.64. Review.

PMID:
20645694
9.

Population screening for prostate cancer and emerging concepts for young men.

Moul JW.

Clin Prostate Cancer. 2003 Sep;2(2):87-97. Review.

PMID:
15040869
10.

Prostate Cancer Screening and the Associated Controversy.

Tabayoyong W, Abouassaly R.

Surg Clin North Am. 2015 Oct;95(5):1023-39. doi: 10.1016/j.suc.2015.05.001. Epub 2015 Jun 23. Review.

PMID:
26315521
11.

The dilemmas of prostate cancer screening.

Hugosson J, Carlsson SV.

Med J Aust. 2013 Jun 3;198(10):528-9. No abstract available.

PMID:
23725256
12.

Racial differences in adenocarcinoma of the prostate in North American men.

Morton RA Jr.

Urology. 1994 Nov;44(5):637-45. Review.

PMID:
7526522
13.

Screening for prostate cancer: an updated review.

Marta GN, Hanna SA, Fernandes da Silva JL, Carvalho Hde A.

Expert Rev Anticancer Ther. 2013 Jan;13(1):101-8. doi: 10.1586/era.12.154. Review.

PMID:
23259431
14.

[Does a low PSA at 60 years old exclude the risk of developing prostate carcinoma?].

Zürcher S.

Rev Med Suisse. 2014 Jun 11;10(434):1316. French. No abstract available.

PMID:
25073308
15.

Active surveillance for prostate cancer: a review.

Klotz L.

Curr Urol Rep. 2010 May;11(3):165-71. doi: 10.1007/s11934-010-0110-z. Review.

PMID:
20425623
16.

American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.

Carter HB.

BJU Int. 2013 Sep;112(5):543-7. doi: 10.1111/bju.12318. Review.

17.

Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?

Jackson BR.

Arch Pathol Lab Med. 2013 Mar;137(3):308-9. doi: 10.5858/arpa.2012-0241-ED. Epub 2012 Jul 16. No abstract available.

PMID:
22799565
18.

A Calculator for Prostate Cancer Risk 4 Years After an Initially Negative Screen: Findings from ERSPC Rotterdam.

Roobol MJ, Zhu X, Schröder FH, van Leenders GJ, van Schaik RH, Bangma CH, Steyerberg EW.

Eur Urol. 2013 Apr;63(4):627-33. doi: 10.1016/j.eururo.2012.07.029. Epub 2012 Jul 20.

PMID:
22841675
19.

Prostate-specific antigen screening for prostate cancer in older men in the United States of America.

Black A, Berg CD.

Gerontology. 2012;58(4):331-6. doi: 10.1159/000334242. Epub 2012 Feb 16.

PMID:
22343605
20.

Supplemental Content

Support Center